UK Researchers Launch Unbiased AI Testing Platform for Diabetic Retinopathy Screening

Researchers unveiled a new independent platform for fair, large-scale evaluation of commercial AI algorithms detecting diabetic eye disease within the NHS.
Key Details
- 1First real-world head-to-head platform to evaluate commercial AI algorithms for NHS use in detecting diabetic eye disease.
- 2Eight CE marked AI algorithms tested on 1.2 million retinal images from one of the UK’s largest and most diverse screening programs.
- 3Algorithm performance (accuracy) ranged from 83.7% to 98.7% for clinically relevant diabetic eye disease, outperforming or matching human graders.
- 4Algorithms’ accuracy remained consistent across varied ethnic groups; first such assessment at this scale.
- 5AI analyzed images in 240ms–45s compared to up to 20 minutes for humans, vastly improving efficiency.
- 6Funded by NHS Transformation Directorate, The Health Foundation, and Wellcome Trust; study published in The Lancet Digital Health.
Why It Matters

Source
EurekAlert
Related News

AI-Based Imaging Biomarker for Chronic Stress Validated on Chest CT
A deep learning model has identified and validated the first imaging biomarker for chronic stress using adrenal gland measurements from routine chest CT scans.

Multi-Algorithm Machine Learning Model Enhances Exacerbation Risk Prediction in COPD
A multi-algorithm machine learning model significantly improves risk prediction of acute exacerbations in COPD patients using multidimensional clinical data.

AI Simplifies CT Reports, Boosting Cancer Patients' Understanding
AI-driven text simplification significantly improves cancer patients' comprehension of CT scan reports.